Jacqueline Talea Desjardin, MD
NPI 1699207217ActiveIndividual· Internal Medicine, Advanced Heart Failure and Transplant Cardiology· San Francisco, CA
Internal Medicine, Advanced Heart Failure and Transplant Cardiology (MD) in San Francisco, California, trained at University of California, San Francisco School of Medicine (class of 2017). Their prescriptions cost Medicare Part D more than their services did: $58,693 for 62 claims, against $17,067 paid for services in 2024. United Therapeutics Corporation was the largest of 2 companies reporting payments in 2025, $248.48 in all, mostly food and beverage.
Overview
| NPI | 1699207217 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | Apr 2, 2017 |
| Last updated in NPPES | Sep 29, 2025 |
| Certified by provider | Sep 29, 2025 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Advanced Heart Failure and Transplant Cardiology Primary | 207RA0001X | A160404 | CA |
| Internal Medicine | 207R00000X | A160404 | CA |
| Internal Medicine, Cardiovascular Disease | 207RC0000X | A160404 | CA |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 4, 2026 | No match | — |
| New York OMIG · Nov 4, 2026 | No match | — |
| Ohio Medicaid · Nov 4, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 4, 2026 | No match | — |
| Washington HCA · Nov 4, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Adult Congenital Heart Disease (Achd) (CA) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 43 |
|---|---|
| Services billed | 239 across 13 procedure codes |
| Paid by Medicare | $17,067 |
Part D prescriptions in 2024
| Prescriptions (claims) | 62 · 91 30-day fills |
|---|---|
| Patients | 21 |
| Total drug cost | $58,693 |
| Generic share | 73% of claims |
Education and affiliations
| Medical school | University of California, San Francisco School of Medicine |
|---|---|
| Graduation year | 2017 |
| Medicare specialty | Adult Congenital Heart Disease (Achd) |
| Secondary specialties | Cardiovascular Disease (Cardiology), Internal Medicine |
| Telehealth | Offers telehealth |
Medical groups
- University of California San FranciscoSan Francisco, CA · 1,839 clinicians
- UCSF Medical Group Business ServicesSan Francisco, CA · 1,598 clinicians
- Regents of the University of CaliforniaSan Francisco, CA · 732 clinicians
Hospital affiliations
- UCSF Health St. Mary's HospitalSan Francisco, CA
- UCSF Medical CenterSan Francisco, CA
Industry payments (Open Payments)
- 2025$248.48 · 3 payments from 2 companies
- 2024$552.71 · 8 payments from 3 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| United Therapeutics Corporation | $158.45 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $90.03 | 1 |
What the 2025 payments were for
- Food and Beverage$248.48 · 3 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in San Francisco
- 1720377146
- 1861811044
- 1003254186
- 1669420956
- 1942162144
- 1386873370
- 1184959272
- 1235199340
- 1699113407
- 1942437470
- 1184157323
- 1194735019
All Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in California →